Cyclosporine before PCI in Patients with Acute Myocardial Infarction

Cited by (714)

Items 301–400 of 714

1. Advances in Coronary No-Reflow Phenomenon—a Contemporary Review
   Ahmadreza Karimianpour, Anbukarasi Maran · 2018 · Current Atherosclerosis Reports
2. Effects of tirofiban on stent thrombosis, Hs-CRP, IL-6 and sICAM-1 after PCI of acute myocardial infarction
   Yuqing Zhang, Tingguo Shao, Lei Yao, Yue Hong, Zhiyu Zhang · 2018 · Experimental and Therapeutic Medicine
3. Translation, Translation, Translation
   Gerd Heusch, Andreas Skyschally, Petra Kleinbongard · 2018 · Circulation Research
4. The unmet promise: a critical review of antioxidant strategies in myocardial ischemia-reperfusion injury and the path towards precision medicine
   Hao Chen, Yutao Tang, Pan Ren, Wen‐Bin Wu · 2025 · Frontiers in Pharmacology
5. Mitochondrial Ca2+ and cell cycle regulation
   Haixin Zhao, Xin Pan · 2021 · International review of cytology
6. Imaging Inflammation Past, Present, and Future: Focus on Cardioimmunology
   James T. Thackeray, Kory J. Lavine, Yongjian Liu · 2023 · Journal of Nuclear Medicine
7. Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: A meta-analysis
   Sunil Upadhaya, Seetharamprasad Madala, Ramkaji Baniya, Suresh Kumar Subedi, Kalyan Saginala, Ghassan I. Bachuwa · 2016 · Cardiology Journal
8. Preventing permeability transition pore opening increases mitochondrial maturation, myocyte differentiation and cardiac function in the neonatal mouse heart
   Jayson V. Lingan, Ryan Earl Alanzalon, George A. Porter · 2017 · Pediatric Research
9. Therapeutic implications of novel peptides targeting ER–mitochondria Ca2+-flux systems
   Martijn Kerkhofs, Geert Bultynck, Tim Vervliet, Giovanni Monaco · 2019 · Drug Discovery Today
10. Molecular Signaling to Preserve Mitochondrial Integrity against Ischemic Stress in the Heart: Rescue or Remove Mitochondria in Danger
    Justin D. Yu, Shigeki Miyamoto · 2021 · Cells
11. Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty
    Cristóbal Ramos, Roberto Brito, Jaime González‐Montero, Nicolás Valls, Juan Guillermo Gormaz, Juan Carlos Prieto, Rubén Aguayo, Ángel Puentes, Viviana Noriega, Gonzalo Pereira et al. · 2016 · Archives of Medical Science
12. Hypertrophic preconditioning attenuates myocardial ischemia/reperfusion injury through the deacetylation of isocitrate dehydrogenase 2
    Leilei Ma, Hongtao Shi, Yang Li, Wei Gao, Junjie Guo, Jianbing Zhu, Zheng Dong, Aijun Sun, Yunzeng Zou, Junbo Ge · 2021 · 中国科学通报：英文版
13. The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling
    Luke Spray, Catherine Park, Suzanne Cormack, Ashfaq Mohammed, Pedram Panahi, Stephen E. Boag, Karim Bennaceur, Kateryna Sopova, Gavin David Richardson, Verena Stangl et al. · 2021 · Frontiers in Immunology
14. Impact of postconditioning with lactate-enriched blood on in-hospital outcomes of patients with ST-segment elevation myocardial infarction
    Takashi Koyama, Masahito Munakata, Takashi Akima, Toshimi Kageyama, Masaru Shibata, Kazunori Moritani, Hideaki Kanki, Shiro Ishikawa, Hideo Mitamura · 2016 · International Journal of Cardiology
15. Preclinical trial of a MAP4K4 inhibitor to reduce infarct size in the pig: does cardioprotection in human stem cell-derived myocytes predict success in large mammals?
    Maaike te Lintel Hekkert, Gary K. Newton, Kathryn Chapman, Rehan Aqil, Robert Downham, Robert Yan, Daphne Merkus, Gavin A. Whitlock, Charlotte A. L. Lane, Darren Cawkill et al. · 2021 · Basic Research in Cardiology
16. Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
    Laura Chaffey, Annabell Roberti, David R. Greaves · 2022 · Frontiers in Pharmacology
17. Cyclophilin D in Mitochondrial Dysfunction: A Key Player in Neurodegeneration?
    Gabriele Coluccino, Valentina Pia Muraca, Alessandra Corazza, Giovanna Lippe · 2023 · Biomolecules
18. Mitochondria in Ischemic Heart Disease
    Louis Maximilian Buja · 2017 · Advances in experimental medicine and biology
19. A novel therapeutic peptide targeting myocardial reperfusion injury
    Prisca Boisguérin, Aurélie Covinhes, Laura Gallot, Christian Barr�re, Anne Vincent, Muriel Busson, Christophe A. Piot, Joël Nargeot, Bernard Lebleu, Stéphanie Barrère‐Lemaire · 2019 · Cardiovascular Research
20. Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models
    Andrea Baehr, Nikolai Klymiuk, Christian Kupatt · 2019 · International Journal of Molecular Sciences
21. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
    Xavier Rosselló, Antonio Rodríguez‐Sinovas, Gemma Vilahur, Verónica Crisóstomo, Inmaculada Jorge, Carlos Zaragoza, José Luis Zamorano, Javier Bermejo, Antonio Ordóñez, Lisardo Boscá et al. · 2019 · Scientific Reports
22. Perioperative Cardioprotection: Clinical Implications
    Sebastian Roth, Carolin Torregroza, Ragnar Huhn, Markus Werner Hollmann, Benedikt Preckel · 2020 · Anesthesia & Analgesia
23. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol – The COVERT-MI Study
    Didier Bresson, François Roubille, Cyril Prieur, Loïc Bière, Fabrice Ivanés, Claire Bouleti, Olivier Dubreuil, Gilles Rioufol, Florent Boutitie, Georges Sideris et al. · 2021 · Cardiology
24. A Review of Basic Fibroblast Growth Factor Delivery Strategies and Applications in Regenerative Medicine
    Yuhan Tu, Yang Li, Gao-Er Qu, Yangyang Ning, Bin Li, Guoben Li, Min Wu, Shijun Li, Yangge Huang · 2024 · Journal of Biomedical Materials Research Part A
25. Anti-inflammatory pharmacotherapy in patients with cardiovascular disease
    Simone Finocchiaro, Placido Maria Mazzone, Nicola Ammirabile, Carla Bordonaro, Carmelo Cusmano, Luigi Cutore, Giacinto Di Leo, Denise Cristiana Faro, Daniele Giacoppo, Antonio Greco et al. · 2025 · European Heart Journal - Cardiovascular Pharmacotherapy
26. Unacylated ghrelin analog prevents myocardial reperfusion injury independently of permeability transition pore
    Rania Harisseh, Bruno Pillot, Abdallah Gharib, Lionel Augeul, Noëlle Gallo-Bona, René Ferrera, Joseph Loufouat, Thomas Delale, Soraya Allas, Thierry Abribat et al. · 2016 · Basic Research in Cardiology
27. Remote Ischemic Conditioning for Patients With STEMI
    Michael Rahbek Schmidt, Mathis Ersted Rasmussen, Hans Erik Bøtker · 2017 · Journal of Cardiovascular Pharmacology and Therapeutics
28. Effect of Cangrelor on Infarct Size in ST-Segment–Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial (The PITRI Trial)
    Heerajnarain Bulluck, Jun Hua Chong, Jennifer Bryant, Annitha Annathurai, Ping Chai, Mervyn H.H. Chan, Ashish Chawla, Chee Yang Chin, Yiu‐Cho Chung, Fei Gao et al. · 2024 · Circulation
29. Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction
    Rebecca Maria Parodi‐Rullán, Jadira Soto‐Prado, Jesús Vega‐Lugo, Xavier R. Chapa‐Dubocq, Sara Isabel Diaz‐Cordero, Sabzali A. Javadov · 2018 · Cellular Physiology and Biochemistry
30. Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction
    Yuya Ide, Takahiro Horie, Naritatsu Saito, Shin Watanabe, Chiharu Otani, Yui Miyasaka, Yasuhide Kuwabara, Tomohiro Nishino, Tetsushi Nakao, Masataka Nishiga et al. · 2019 · JACC Basic to Translational Science
31. Approaches to Improving Cardiac Structure and Function During and After an Acute Myocardial Infarction
    Robert Alan Kloner, Wangde Dai, Sharon L. Hale, Jianru Shi · 2015 · Journal of Cardiovascular Pharmacology and Therapeutics
32. Effects of OP2113 on Myocardial Infarct Size and No Reflow in a Rat Myocardial Ischemia/Reperfusion Model
    Wangde Dai, Nívea Dias Amoêdo, Justin B. Perry, Bruno Le Grand, Aurélie Boucard, Juan Eduardo Carreño, Lifu Zhao, David A. Brown, Rodrigue Rossignol, Robert Alan Kloner · 2021 · Cardiovascular Drugs and Therapy
33. Impact of Machine Perfusion on the Immune Response After Liver Transplantation – A Primary Treatment or Just a Delivery Tool
    Rebecca Panconesi, Mauricio Flores Carvalho, Daniele Eliseo Dondossola, Paolo Muiesan, Philipp Dutkowski, Andrea A. Schlegel · 2022 · Frontiers in Immunology
34. Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction
    Maxwell Quinn, Richard Ying Ke Zhang, Idris Bello, Kerry‐Anne Rye, Shane Ross Thomas · 2024 · Antioxidants
35. A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study
    Claudio Laudani, Giovanni Occhipinti, Antonio Greco, Daniele Giacoppo, Marco Spagnolo, Davide Capodanno · 2025 · European Heart Journal - Cardiovascular Pharmacotherapy
36. Skeletal muscle ischemia–reperfusion injury and cyclosporine A in the aging rat
    Julien Pottecher, Michel J. Kindo, Thiên‐Nga Chamaraux‐Tran, Anne‐Laure Charles, Anne Lejay, Véronique Kemmel, Thomas Vogel, Nabil Chakfé, Joffrey Zoll, Pierre Auguste Diemunsch et al. · 2016 · Fundamental and Clinical Pharmacology
37. Development of a novel one-step production system for injectable liposomes under GMP
    Ryo Araki, Takashi Matsuzaki, Ayumi Nakamura, Daisaku Nakatani, Shoji Sanada, Hai Ying Fu, Keiji Okuda, Masaki Yamato, Shota Tsuchida, Yasushi Sakata et al. · 2017 · Pharmaceutical Development and Technology
38. China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial
    Yi Xu, Xiangdong Li, Haitao Zhang, Yuan Wu, Jun Zhang, Jia Li, Kefei Dou, Hongbing Yan, Shijie You, Yanmin Yang et al. · 2020 · American Heart Journal
39. Acute myocardial infarction and cardiogenic shock: Should we unload the ventricle before percutaneous coronary intervention?
    Behnam N. Tehrani, Mir B. Basir, Navin Kumar Kapur · 2020 · Progress in Cardiovascular Diseases
40. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction
    Alessandro Bellis, Ciro Mauro, Emanuele Barbato, Giuseppe Di Gioia, Daniela Sorriento, Bruno Trimarco, Carmine Morisco · 2020 · Cells
41. Targeting myocardial reperfusion injuries with cyclosporine in the CIRCUS T rial – pharmacological reasons for failure
    Laurent Monassier, Estelle Ayme‐Dietrich, Gaëlle Aubertin-Kirch, Atul Pathak · 2015 · Fundamental and Clinical Pharmacology
42. Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus
    Jozef Bartunek, Wojtek Wojakowski · 2017 · European Heart Journal
43. Modulation of mitochondrial permeability transition pores in reperfusion injury: Mechanisms and therapeutic approaches
    Giampaolo Morciano, Paolo Pinton · 2024 · European Journal of Clinical Investigation
44. Nrg1β Released in Remote Ischemic Preconditioning Improves Myocardial Perfusion and Decreases Ischemia/Reperfusion Injury via ErbB2-Mediated Rescue of Endothelial Nitric Oxide Synthase and Abrogation of Trx2 Autophagy
    Venkatesh Kundumani‐Sridharan, Jaganathan Subramani, Cade Owens, Kumuda C. Das · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
45. Cyclophilin D regulation of the mitochondrial permeability transition pore
    Elizabeth Murphy · 2022 · Current Opinion in Physiology
46. Macrophage heterogeneity in myocardial infarction: Evolution and implications for diverse therapeutic approaches
    Babunageswararao Kanuri, Gopalkrishna Sreejit, Priosmita Biswas, Andrew James Murphy, Prabhakara R. Nagareddy · 2024 · iScience
47. The adenine nucleotide translocase family underlies cardiac ischemia-reperfusion injury through the mitochondrial permeability pore independently of cyclophilin D
    Pooja Patel, Arielys Mendoza, Daniel Ramirez, Dexter J. Robichaux, Jeffery D. Molkentin, Jason M. Karch · 2024 · Science Advances
48. Molecular mechanism of ischemia — Reperfusion injury after myocardial infarction and its possible targeted treatment
    Ján Lakota · 2016 · International Journal of Cardiology
49. Reperfusion injury in ST-segment elevation myocardial infarction
    Gjin Ndrepepa, Róisín Colleran, Adnan Kastrati · 2017 · Coronary Artery Disease
50. Pharmacological postconditioning with atorvastatin calcium attenuates myocardial ischemia/reperfusion injury in diabetic rats by phosphorylating GSK3β
    Linyan Chen, Ping Cai, Zhendong Cheng, Zai-Bao Zhang, Jun Fang · 2017 · Experimental and Therapeutic Medicine
51. The role of acute circulatory support in ST-segment elevation myocardial infarction complicated by cardiogenic shock
    MICHELE L. ESPOSITO, Yousef H. Bader, Robert Pedicini, Catalina Breton, Andrew Mullin, Navin Kumar Kapur · 2017 · Indian Heart Journal
52. Acute Intravenous Infusion of Immunoglobulins Protects Against Myocardial Ischemia-Reperfusion Injury Through Inhibition of Caspase-3
    Waleed Al–Herz, Fawzi A. Babiker · 2017 · Cellular Physiology and Biochemistry
53. Circadian rhythm and ischaemia–reperfusion injury
    Thomas Bochaton, Michel Ovize · 2017 · The Lancet
54. Platelet inhibition to target reperfusion injury trial: Rationale and study design
    Heerajnarain Bulluck, Mervyn H.H. Chan, Jennifer Bryant, Ping Chai, Ashish Chawla, Terrance S. J. Chua, Yiu‐Cho Chung, Fei Gao, Hee Hwa Ho, Andrew Fu Wah Ho et al. · 2018 · Clinical Cardiology
55. Increased cerebral mitochondrial dysfunction and reactive oxygen species with cardiopulmonary bypass
    Lindsay E. Volk, Constantine D. Mavroudis, Tiffany S. Ko, Thomas Hallowell, Nile Delso, Anna L. Roberts, Jonathan P. Starr, William P. Landis, Yuxi Lin, Marco M. Hefti et al. · 2020 · European Journal of Cardio-Thoracic Surgery
56. Remote Ischemic Conditioning in Emergency Medicine—Clinical Frontiers and Research Opportunities
    Andrew Fu Wah Ho, Jun Hua Chong, Marcus Eng Hock Ong, Derek John Hausenloy · 2019 · Shock
57. Reperfusion injury in STEMI: a double-edged sword
    Krupa Sara Thomas, Divina Mariya Puthooran, Sudeep Edpuganti, Adi Lakshmi Reddem, Angela Jose, Swathi Akula · 2025 · The Egyptian Heart Journal
58. Extracellular RNA drives TNF-α/TNF-receptor-1 mediated cardiac ischemia/reperfusion injury: Mechanistic insights and therapeutic potential of RNase1
    Héctor A. Cabrera-Fuentes, Marisol Ruiz‐Meana, Guillermo Barreto, Victor L. Serebruany, José Trinidad Sánchez Vega, Eduardo Pérez‐Campos, Sawa Kostin D, Andreas Boening, Efrén Emmanuel Jarquín González, Ebtesam Abdullah Al-Suhaimi et al. · 2025 · Pharmacological Research
59. CLEC3B protects H9c2 cardiomyocytes from apoptosis caused by hypoxia via the PI3K/Akt pathway
    Fenghua Lv, Zhuo Wang, Yanli Huang, Aoyang Si, Yulei Chen · 2020 · Brazilian Journal of Medical and Biological Research
60. The interplay between T lymphocytes and macrophages in myocardial ischemia/reperfusion injury
    Dan Li, Shan Gao · 2023 · Molecular and Cellular Biochemistry
61. Pharmaceutical Manipulation of Mitochondrial F0F1‐ATP Synthase Enables Imaging and Protection of Myocardial Ischemia/Reperfusion Injury Through Stress‐induced Selective Enrichment
    Zelin Chen, Xu Tan, Taotao Jin, Yu Wang, Linyong Dai, Gufang Shen, Can Zhang, Langfan Qu, Lei Long, Chongxing Shen et al. · 2023 · Advanced Science
62. The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields
    Iyad Y. Natsheh, Majd M. Alsaleh, Ahmad Khalaf Alkhawaldeh, Duaa K. Albadawi, Maisa’ M. Darwish, Mohammad Jamal A. Shammout · 2024 · Drug Target Insights
63. A randomised trial of selective intracoronary hypothermia during primary PCI
    Mohamed El Farissi, Nico H.J. Pijls, Richard Good, Thomas Engstrøm, Thomas Keeble, Branko Beleslin, Bernard De Bruyne, Ole Fröbert, David Erlinge, Koen Teeuwen et al. · 2024 · EuroIntervention
64. Low-energy cardiac shockwave therapy to suppress left ventricular remodeling in patients with acute myocardial infarction
    Yuta Kagaya, Kenta Ito, JUN C. TAKAHASHI, Yasuharu Matsumoto, Takashi Shiroto, Ryuji Tsuburaya, Yoku Kikuchi, Kiyotaka Hao, Kensuke Nishimiya, Tomohiko Shindo et al. · 2017 · Coronary Artery Disease
65. The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species
    Martin Stroethoff, Lukas Goetze, Carolin Torregroza, Sebastian Bunte, Annika Raupach, André Heinen, Alexander Mathes, Markus Werner Hollmann, Ragnar Huhn · 2020 · Cardiovascular Drugs and Therapy
66. Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5' adenosine monophosphate‐activated protein kinase/nuclear factor erythroid 2‐related factor pathway and changes in the mitochondrial state
    Chennian Xu, Yang Liu, Jian Yang, Mengen Zhai, Zhenge Fan, Rui Qiao, Ping Jin, Lifang Yang · 2022 · BioFactors
67. Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients
    Thomas Bochaton, Marc J. Claeys, David García‐Dorado, Nathan Mewton, Cyrille Bergerot, Claire Jossan, Camille Amaz, Inesse Boussaha, Hélène Thibault, Michel Ovize · 2019 · Basic Research in Cardiology
68. Nanoparticle Delivery of Mitoprotective Agents to Target Ischemic Heart Disease
    Sang‐Bing Ong, Shengjie Lu, Khairunnisa Katwadi, Nur Izzah Ismail, Xiu-Yi Kwek, Derek John Hausenloy · 2017 · Future Cardiology
69. Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury
    Joshua Hefler, Braulio A. Marfil‐Garza, Sandy Campbell, Darren H. Freed, A. M. James Shapiro · 2022 · Annals of Translational Medicine
70. Targeting the molecular mechanisms of ischemic damage: Protective effects of alpha-crystallin-B
    Judit Cubedo, Gemma Vilahur, Laura Casaní, Guiomar Mendieta, Efrem Gómez-Jabalera, Oriol Juan‐Babot, Teresa Padró, Lina Badimón · 2016 · International Journal of Cardiology
71. A small-molecule DS44170716 inhibits Ca2+-induced mitochondrial permeability transition
    Naohiro Kon, Atsushi Satoh, Naoki Miyoshi · 2017 · Scientific Reports
72. Hypertrophic preconditioning attenuates post-myocardial infarction injury through deacetylation of isocitrate dehydrogenase 2
    Leilei Ma, Fei‐Juan Kong, Yuanji Ma, Junjie Guo, Shijun Wang, Zheng Dong, Aijun Sun, Yunzeng Zou, Junbo Ge · 2021 · Acta Pharmacologica Sinica
73. Current Status of Stem Cells in Cardiac Repair
    Robert J. Henning · 2018 · Future Cardiology
74. Loss of PKA regulatory subunit 1α aggravates cardiomyocyte necrosis and myocardial ischemia/reperfusion injury
    Yuening Liu, Jingrui Chen, Peng Xia, Constantine A. Stratakis, Zhaokang Cheng · 2021 · Journal of Biological Chemistry
75. Mitochondria as therapeutic targets for Natural Products in the treatment of Cardiovascular Diseases
    Yanze Yang, Felix Boahen Owusu, Han Wu, Xinyue Zhang, Ruiqiao Li, Zhanbiao Liu, Shaozhuo Zhang, Ling Leng, Qilong Wang · 2025 · Journal of Ethnopharmacology
76. Crosstalk between cyclophilins and T lymphocytes in coronary artery disease
    Sandra Gegunde, Amparo Alfonso, Rebeca Alvariño, Eva Alonso, Carlos González‐Juanatey, Luis Miguel Botana · 2021 · Experimental Cell Research
77. Pathophysiology of Reperfusion Injury
    Prue Cowled, Robert Fitridge · 2020 · Springer eBooks
78. Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size
    Rachael E. Redgrave, Esha Singh, Simon Tual‐Chalot, Catherine Park, Darroch H. Hall, Karim Bennaceur, Danielle J. Smyth, Rick M. Maizels, Ioakim Spyridopoulos, Helen M. Arthur · 2023 · American Journal Of Pathology
79. Cardioprotective strategies in myocardial ischemia-reperfusion injury: Implications for improving clinical translation
    Chao Tong, Bingying Zhou · 2024 · Journal of Molecular and Cellular Cardiology Plus
80. Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials
    Chen Yingzhong, Lin Cai, Chunbin Wang · 2016 · SpringerPlus
81. Effect of ciclosporin on safety, lymphocyte kinetics and left ventricular remodelling in acute myocardial infarction
    Suzanne Cormack, Ashfaq Mohammed, Pedram Panahi, Rajiv Das, Alison J. Steel, Thomas J. Chadwick, Andrew Bryant, Mohaned Egred, Konstantinos Stellos, Ioakim Spyridopoulos et al. · 2020 · British Journal of Clinical Pharmacology
82. The Future of Cardioprotection—Pointing Toward Patients at Elevated Risk as the Target Populations
    Hans Erik Bøtker · 2020 · Journal of Cardiovascular Pharmacology and Therapeutics
83. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution
    Mathieu Panel, Abdelhakim Ahmed‐Belkacem, Isaac Ruiz, Jean‐François Guichou, Jean–Michel Pawlotsky, Bijan Ghaleh, Didier Morin · 2020 · Journal of Pharmacology and Experimental Therapeutics
84. Non-conventional mitochondrial permeability transition: Its regulation by mitochondrial dynamics
    Yisang Yoon, Hakjoo Lee, Marilén Federico, Shey‐Shing Sheu · 2022 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
85. Percutaneous Coronary Intervention: 2015 in Review
    Cindy Lee Grines, Kishore J. Harjai, THEODORE L. SCHREIBER · 2016 · Journal of Interventional Cardiology
86. Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition
    Ming-He Huang, Kian Keong Poh, Huay Cheem Tan, Frederick G.P. Welt, Charles Y. Lui · 2016 · International Journal of Cardiology
87. Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts
    Aida Salameh, Maren Keller, Ingo Dähnert, Stefan Dhein · 2017 · Frontiers in Physiology
88. Effects of captopril and valsartan on ventricular remodeling and inflammatory cytokines after interventional therapy for AMI
    Xiaona Gong, Rao-rao Zhou, Qinhao Li · 2018 · Experimental and Therapeutic Medicine
89. Microcirculation vs. Mitochondria—What to Target?
    Tamara Merz, Nicole Denoix, Markus Stefan Huber-Lang, Mervyn Singer, Peter Radermacher, Oscar McCook · 2020 · Frontiers in Medicine
90. Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
    Gianluca Calogero Campo, Rita Pavasini, Giampaolo Morciano, Michael A. Lincoff, Charles Michael Gibson, Masafumi Kitakaze, Jacob Lønborg, Amrita Ahluwalia, Hideki Ishii, Michael Paul Frenneaux et al. · 2017 · Data in Brief
91. The year in cardiology 2015: acute coronary syndromes
    Gilles Montalescot, Filippo Crea · 2016 · European Heart Journal
92. Pleiotropic role of GAS6 in cardioprotection against ischemia-reperfusion injury
    Chenxi Lu, Yanbin Song, Xiaopeng Wu, Wangrui Lei, Junmin Chen, Xin Zhang, Qiong Liu, Chao Deng, Zhenxing Liang, Ying Chen et al. · 2024 · Journal of Advanced Research
93. Unraveling the relationship among insulin resistance, IGF-1, and amyloid-beta 1–40: Is the definition of type 3 diabetes applicable in the cardiovascular field?
    Alessandra Lucia Fluca, Beatrice Pani, Milijana Janjusevic, Donna R. Zwas, Yosefa Abraham, Matteo Calligaris, Antonio Paolo Beltrami, Flávia Campos Corgosinho, Maria E. Marketou, Stefano D’Errico et al. · 2024 · Life Sciences
94. Possible Role of Interaction between PPAR α and Cyclophilin D in Cardioprotection of AMPK against In Vivo Ischemia-Reperfusion in Rats
    Giselle Barreto‐Torres, Sabzali A. Javadov · 2016 · PPAR Research · Retracted
95. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction
    Marcus Hortmann, S. Robinson, M. Mohr, David Haenel, Maximilian Mauler, Daniela Stallmann, Joel Reinoehl, Daniel Duerschmied, Karlheinz Peter, Christoph Bode et al. · 2017 · International Journal of Cardiology
96. Kinetics Analysis of Circulating MicroRNAs Unveils Markers of Failed Myocardial Reperfusion
    Jose Coelho‐Lima, Ashfaq Mohammed, Suzanne Cormack, Samuel Jones, Adnan Ali, Pedram Panahi, Matt J. Barter, Alan J. Bagnall, Simi Ali, David Alan Young et al. · 2019 · Clinical Chemistry
97. New Therapies for Acute Myocardial Infarction: Current State of Research and Future Promise
    Romain Itier, Jerome G. Roncalli · 2018 · Future Cardiology
98. The histone deacetylase inhibitor SAHA exerts a protective effect against myocardial ischemia/reperfusion injury by inhibiting sodium-calcium exchanger
    Xiaocui Shi, Yajuan Yin, Xuwen Guo, Mei Liu, Fangfang Ma, Tian Xiang Li, Mingqi Zheng, Gang Liu · 2023 · Biochemical and Biophysical Research Communications
99. Therapeutic strategies to ameliorate mitochondrial oxidative stress in ischaemia-reperfusion injury: A narrative review
    Khalid Alotaibi, Nishkantha Arulkumaran, Alex Dyson, Mervyn Singer · 2025 · Clinical Science
100. Deferred versus conventional stent implantation in patients with acute ST-segment elevation myocardial infarction: An updated meta-analysis of 10 studies
     Joo Myung Lee, Tae‐Min Rhee, Haseong Chang, Chul Ahn, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Seung‐Hyuk Choi, Hyeon‐Cheol Gwon, Joo‐Yong Hahn · 2016 · International Journal of Cardiology